Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 73 filings.
24 Aug 2026 2 filings
Capital / Securities
Aug 24, 2026: Nomination and Remuneration Committee approved allotment of 25,691 equity shares on ESOP exercise.
Consequently, on Aug 24, 2026, issued capital increased to Rs 455,161,426 comprising 227,580,713 equity shares.
14 Aug 2026 2 filings
US subsidiary mergers
M3BI LLC merger with Zensar Technologies Inc. becomes effective on September 1, 2026.
Bridgeview Life Sciences LLC merger filings completed with Zensar Technologies Inc.
All requisite local filings for both mergers completed; post-merger filings remain in process.
Intimation of M3BI merger received at 1:43 a.m. IST on August 14, 2026.
US subsidiary mergers status
Mergers of Bridgeview Life Sciences LLC and M3BI LLC with Zensar Technologies Inc. have completed requisite filings.
M3BI LLC merger with Zensar Technologies Inc. becomes effective from September 1, 2026.
Bridgeview Life Sciences LLC merger filings completed; post-merger and consequential filings remain in process.
10 Aug 2026 1 filing
Meeting Details
Aug 13, 2026, 1:00 p.m. onwards; Equirus Annual India Conference 2026; In-person group meeting; Purpose: investor interaction.
Aug 14, 2026, 10:00 a.m. onwards; Emkay Confluence 2026 – India: Full Throttle Ahead; Purpose: investor interaction.
30 Jul 2026 1 filing
Meeting Details
Date and time: July 30, 2026, 08:30 IST.
Type and mode: earnings call, audio recording.
Event organiser: Q1FY27 earnings call by Zensar Technologies.
Key company participant: Company Secretary.
Purpose: discuss Q1FY27 results, quarter ended June 30, 2026.
Availability: recording updated on Investors Corner website.
Participants
Key participant: Company Secretary (management role).
Purpose
Discuss Q1FY27 results, quarter ended June 30, 2026.
Additional Notes
Recording available on the company's Investors Corner.
Transcript not mentioned.